A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Treatment Gaining Traction Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers market the drug there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Professionals Voice Concerns
Nevertheless, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users injecting substances of unknown origin.
Several experts stated the popularity for retatrutide could be connected to the increasing cost of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking penalties, prosecution or prison.
Service Reaction and Material Removal
According to the social media company, the service has taken down problematic content and banned related keywords and query recommendations. The organization said it was committed to maintaining the platform safe and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Research also found communities with up to nine thousand participants marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, filled with images of weight loss, positive testimonials and detailed instructions for mixing or injecting at residence.
After minutes of joining one group, a vendor shared contact information, where the majority of transactions take place. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.
Product Information and Pricing
Within these groups, messages display dark colored parcels with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service said it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to possibly serious medical dangers”.
